Michael Donovan

6161 E. Mayo Boulevard
Lecturer (FSC)


Michael Donovan comes to the College of Health Solutions with a unique background.  For the last 11+ years, Michael has been a registered patent attorney (BS – Microbiology; PhD Immunology) specializing in patent prosecution and intellectual-property licensing/commercialization for life sciences-related technologies. After leaving private practice, Michael worked as the Intellectual Property Counsel for The Translational Genomics Research Institute (TGen) and recently served as the System Director for Intellectual Property at CommonSpirit Health.  He has protected and commercialized a multitude of different technologies, including medical devices, biomedical diagnostics and therapeutics, among other technologies. 

In addition to legal practice, Michael has also served as an adjunct faculty member at both ASU and Grand Canyon University.  Michael also serves on the Arizona Supreme Court’s Committee on Examinations.


J.D., Sandra Day O'Connor College of Law, Arizona State University

Ph.D., Biological Sciences, University of Notre Dame

B.S., Microbiology, University of Michigan


Legal Publications  

MJ Donovan, Legal Issues Stemming from the Advancement of Pharmacogenomics, 2010 UCLA J.L. & TECH 1 (2010). 

MJ Donovan, The Impact of “Hurricane” Hannah:  The Government’s Decision to Compensate in One Girl’s Vaccine Injury Case Could Drastically Alter the Face of Public Health, 50 JURIMETRICS J. 229 (2010). 

MJ Donovan, Genetically Modified Insects:  Why Do We Need Them and How Will They be Regulated?, 17 MO. ENVTL. L. & POL’Y REV. 62 (2010). 

MJ Donovan, The Impact of MedImmune, Inc. v. Genentech, Inc. and Its Progeny on Technology Licensing, 3 PEPPERDINE J. BUS., ENTREPRENEURSHIP & L. 40 (2010). 

Science Publications  

MA Bohl et al., The Barrow Innovation Center: A Model for Training Neurosurgical Innovators, Congress Quarterly, Congress of Neurological Surgery, June 2020 (https://www.cns.org/publications/congress-quarterly/congress-quarterly-detail/barrow-innovation-center-model-training-neurosurgi)

MA Bohl et al., The Barrow Innovation Center: A Novel Program in Neurosurgery Resident Education and Medical Device Innovation, 10(2) CUREUS e2142 (2018) (blend of legal and science subjects).   

MJ Donovan et al., Indoleamine 2,3-dioxygenase (IDO) induced by Leishmania infection of human dendritic

cells, 34 PARASITE IMMUNOLOGY 464 (2012). 

MJ Donovan et al., Leishmania Infection Inhibits Cycloheximide-Induced Macrophage Apoptosis in a StrainDependent Manner, 123 EXPERIMENTAL PARASITOLOGY 58 (2009). 

A Jayakumar et al., Leishmania major Infection Activates NF-κB and Interferon Regulatory Factors 1 and 8 in Human Dendritic Cells, 76 INFECTION & IMMUNITY 2138 (2008) (second author). 

MJ Donovan et al., Inhibition of Groups One and Two CD1 Molecules on Human Dendritic Cells by Leishmania Species, 29 PARASITE IMMUNOLOGY 515 (2007). 

O Akilov et al., T Helper Type 1 Cytokines and Keratinocyte Growth Factor Play a Critical Role in 

Pseudoepitheliomatous Hyperplasia During Cutaneous Leishmaniasis, 299 ARCHIVES OF DERMATOLOGICAL RESEARCH 315 (2007) (second author).  

MJ Donovan et al., Uninfected Mosquito Bites Confer Protection Against Infection with Malaria Parasites, 75 INFECTION & IMMUNITY 2523 (2007).  


Summer 2020
Course Number Course Title
NAN 506 Innovation and IP Management
Summer 2019
Course Number Course Title
NAN 506 Innovation and IP Management
Summer 2018
Course Number Course Title
NAN 506 Innovation and IP Management
Summer 2017
Course Number Course Title
NAN 506 Innovation and IP Management


Board Member, Northwest Medical Isotopes, LLC 2018-2021

Board Member, American Liver Foundation 2011-2012

Industry Positions

System Director, Intellectual Property and Strategic Innovation - CommonSpirit Health

Intellectual Property Counsel - TGen